Table 1.
Experiments and treatment groups.
| GSAA Experiment | N | IPCD Experiment | N |
|---|---|---|---|
| “granulocyte stimulation and anti-apoptosis” | “inhibiting programmed cell death” | ||
| Control: | 10 | Control: | 15 |
| Singlets: | Singlets: | ||
| JP4-039 | 10 | JP4-039 | 15 |
| G-CSF | 10 | baicalein | 15 |
| necrostatin-1 | 15 | ||
| Doublet: | Doublets: | ||
| JP4-039 + GCSF | 10 | JP4-039 + baicalein | 15 |
| baicalein + necrostatin-1 | 15 | ||
| JP4-039 + necrostatin-1 | 15 | ||
| Triplet: | |||
| JP4-039 + baicalein + necrostatin-1 | 15 | ||
| Total | 40 | Total | 120 |
This study consists of two experiments, GSAA and ICPD. The GSAA experiment were composed of 4 treatment groups of 10 mice each for a total of 40 subjects. The IPCD experiment was composed of 8 treatment groups of 15 mice each, for a total 120 subjects.